부산대학교 도서관

El-Khoury, Habib ; Lee, David J ; Alberge, Jean-Baptiste ; Redd, Robert ; Cea-Curry, Christian J ; Perry, Jacqueline ; Barr, Hadley ; Murphy, Ciara ; Sakrikar, Dhananjay ; Barnidge, David ; Bustoros, Mark ; Leblebjian, Houry ; Cowan, Anna ; Davis, Maya I ; Amstutz, Julia ; Boehner, Cody J ; Lightbody, Elizabeth D ; Sklavenitis-Pistofidis, Romanos ; Perkins, Mark C ; Harding, Stephen ; Mo, Clifton C ; Kapoor, Prashant ; Mikhael, Joseph ; Borrello, Ivan M ; Fonseca, Rafael ; Weiss, Scott T ; Karlson, Elizabeth ; Trippa, Lorenzo ; Rebbeck, Timothy R ; Getz, Gad ; Marinac, Catherine R ; Ghobrial, Irene M

In The Lancet Haematology May 2022 9(5):e340-e349

Auclair, Daniel ; Bustoros, MD, Mark ; Cibulskis, Carrie ; Dowdell, Teni ; Gavrilov, Svetlana ; Boehner, Cody J ; Yesil, Jennifer ; Labkoff, Steven E. ; Mehr, Shaadi ; Sklavenitis-Pistofidis, Romanos ; Manier, Salomon ; Lightbody, Elizabeth D. ; Kim, Annette S. ; Rhoades, Justin ; Ligon, Keith L ; Lennon, Niall ; Adalsteinsson, Viktor ; Wilkinson, Jane ; Cho, Hearn Jay ; Ghobrial, Irene M.

In Blood 5 November 2020 136 Supplement 1:33-33

Bustoros, MD, Mark ; Nadeem, Omar ; Sperling, Adam S ; Bianchi, Giada ; Ardente, Lily ; Redd, Robert A. ; Prescott, Julia ; Frey, Erin ; Guimond, Kathleen ; Styles, Rachel ; Hornburg, Kalvis ; Savell, Alexandra ; Su, Nang Kham ; Bindra, Govind ; Boehner, Cody J ; Reyes, Kaitlen ; Leblebjian, Houry ; Warren, Diane ; Munshi, Nikhil C. ; Laubach, Jacob P. ; Anderson, Kenneth C. ; Richardson, Paul G. ; Ghobrial, Irene M.

In Blood 13 November 2019 134 Supplement 1:580-580

Nadeem, Omar ; Redd, Robert ; Stampleman, Laura V. ; Matous, Jeffrey V. ; Yee, Andrew J. ; Zonder, Jeffrey A. ; Kin, Andrew ; Rosenblatt, Jacalyn ; Bustoros, MD, Mark ; Prescott, Julia ; Savell, Alexandra ; Guimond, Kathleen ; Frey, Erin ; Styles, Rachel ; Bielawski, Adrienne ; Boehner, Cody J ; Su, Nang Kham ; Multiple Myeloma Research Foundation, Multiple Myeloma Research Foundation ; The Leukemia & Lymphoma Society, The Leukemia & Lymphoma Society ; Blood Cancer Research Partnership, BCRP ; Sperling, Adam S ; Bianchi, Giada ; Laubach, Jacob P. ; Castillo, Jorge J. ; Munshi, Nikhil C. ; Anderson, Kenneth C. ; Richardson, Paul G. ; Trippa, Lorenzo ; Ghobrial, Irene M.

In Blood 13 November 2019 134 Supplement 1:1898-1898

Lightbody ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Sklavenitis-Pistofidis R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Wu T; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Tsuji J; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Firer DT; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Agius MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Dutta AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Barr H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Kim S; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Alberge JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Nersesian S; Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.; Coorens T; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Haradhvala NJ; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Su NK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Boehner CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Aranha MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Rahmat M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Konishi Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Hevenor L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Towle K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Horowitz E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Perry J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Davis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Walsh KA; Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Cea-Curry CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Fleming G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Vinyard ME; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Heilpern-Mallory D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; El-Khoury H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA.; Cowan A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Ready JE; Harvard Medical School, Boston, MA, USA.; Department of Orthopaedic Surgery, Brigham and Women's Hospital, Boston, MA, USA.; Marinac CR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, USA.; Getz G; Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Krantz Family Center for Cancer Research and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.; Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA. irene_ghobrial@dfci.harvard.edu.; Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Liu, Chia-jen ; Ghobrial, Irene M. ; Bustoros, Mark ; Reyes, Kaitlen ; Hornburg, Kalvis ; Badros, Ashraf Z. ; Vredenburgh, James J. ; Boruchov, Adam ; Matous, Jeffrey V ; Caola, Aaron ; Rivotto, Bradley ; Savell, Alexandra ; Henrick, Patrick ; Paba-Prada, Claudia E. ; Schlossman, Robert L. ; Laubach, Jacob ; Rosenblatt, Jacalyn ; Yee, Andrew J ; Nadeem, Omar ; Maegawa, Rodrigo O. ; Jakubowiak, Andrzej ; Usmani, Saad Z. ; Bhutani, Manisha ; Cappuccio, Joseph ; Berrios, Brianna ; Noonan, Kimberly ; Zavidij, Oksana ; Mouhieddine, Tarek H ; Boehner, Cody J ; Neuse, Carl-Jannes ; Salem, Karma Ziad ; Reidy, Mairead ; Park, Jihye ; Agius, Michael ; Rahmat, Mahshid ; Manier, Salomon ; Bhutani, Divaya ; Zonder, Jeffrey A ; Munshi, Nikhil ; Auclair, Daniel ; Anderson, Kenneth ; Richardson, Paul

In Blood 29 November 2018 132 Supplement 1:154-154

Bustoros, Mark ; Sklavenitis-Pistofidis, Romanos ; Liu, Chia-jen ; Kastritis, Efstathios ; Fell, Geoffrey ; Hornburg, Kalvis ; Neuse, Carl-Jannes ; Henrick, Patrick ; Marinac, Catherine R. ; Perilla-Glen, Adriana ; Savell, Alexandra ; Liu, David ; Yosef, Amir ; Rivotto, Bradley ; Soiffer, Jenny ; Dumke, Henry ; Boehner, Cody J ; Reyes, Kaitlen ; Noonan, Kimberly ; Soiffer, Robert J. ; Treon, Steven P ; Castillo, Jorge J. ; Dimopoulos, Meletios A ; Ghobrial, Irene M.

In Blood 29 November 2018 132 Supplement 1:150-150

Mouhieddine, Tarek H ; Park, Jihye ; Redd, Robert A. ; Gibson, Christopher J. ; Manier, Salomon ; Nassar, Amin H ; Capelletti, Marzia ; Huynh, Daisy ; Bustoros, Mark ; Sklavenitis-Pistofidis, Romanos ; Hornburg, Kalvis ; Dumke, Henry ; Itani, Muhieddine M ; Boehner, Cody J ; Liu, Chia-Jen ; AlDubayan, Saud H ; Reardon, Brendan ; Van Allen, Eliezer ; Auclair, Daniel ; Schlossman, Robert L. ; Munshi, Nikhil ; Anderson, Kenneth ; Steensma, David P. ; Laubach, Jacob ; Richardson, Paul ; Ritz, Jerome ; Ebert, Benjamin L. ; Soiffer, Robert J. ; Neuberg, Donna S ; Ghobrial, Irene M.

In Blood 29 November 2018 132 Supplement 1:749-749

Bustoros, Mark ; Park, Jihye ; Salem, Karma Ziad ; Liu, Chia-Jen ; Capelletti, Marzia ; Huynh, Daisy ; Tai, Yu-Tzu ; Mouhieddine, Tarek H ; Freeman, Samuel ; Ha, Gavin ; Rhoades, Justin ; Reed, Sarah ; Gydush, Gregory ; Rotem, Denisse ; Perilla Glen, Adriana ; Henrick, Patrick ; Caola, Aaron ; Rivotto, Bradley ; Savell, Alexandra ; Noonan, Kimberly ; Reyes, Kaitlen ; Sacco, Antonio ; Boehner, Cody J ; Leblebjian, Houry ; Liu, David ; Morgan, Elizabeth A ; Roccaro, Aldo M. ; Paba-Prada, Claudia ; Van Allen, Eliezer ; Love, Christopher ; Adalsteinsson, Viktor ; Laubach, Jacob ; Schlossman, Robert ; Munshi, Nikhil ; Richardson, Paul G ; Anderson, Kenneth C ; Kumar, Shaji K ; Getz, Gad ; Ghobrial, Irene M ; Manier, Salomon

In Blood 8 December 2017 130 Supplement 1:392-392

Alberge JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dutta AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Poletti A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.; Coorens THH; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lightbody ED; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Toenges R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Loinaz X; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Wallin S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Dunford A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Priebe O; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Dagan J; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Boehner CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Horowitz E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Su NK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Barr H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hevenor L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Towle K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Beesam R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Beckwith JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Perry J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cordas Dos Santos DM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Bertamini L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Greipp PT; Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA.; Kübler K; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center of Functional Genomics, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Hematology, Oncology and Cancer Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Krantz Family Center for Cancer Research and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Arndt PF; Department of Computational Molecular Biology, Max Planck Institute for Molecular Genetics, Berlin, Germany.; Terragna C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Zamagni E; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy.; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Boyle EM; Department of Haematology, Cancer Institute, University College London Cancer Institute, London, UK.; Yong K; Department of Haematology, Cancer Institute, University College London Cancer Institute, London, UK.; Morgan G; Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Walker BA; Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA.; Dimopoulos MA; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Kastritis E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.; Hess J; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Sklavenitis-Pistofidis R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Stewart C; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Getz G; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. gadgetz@broadinstitute.org.; Krantz Family Center for Cancer Research and Department of Pathology, Massachusetts General Hospital, Boston, MA, USA. gadgetz@broadinstitute.org.; Department of Pathology, Harvard Medical School, Boston, MA, USA. gadgetz@broadinstitute.org.; Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. irene_ghobrial@dfci.harvard.edu.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. irene_ghobrial@dfci.harvard.edu.

Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE

Mouhieddine TH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Redd R; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Leventhal M; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Gibson CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Manier S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Department of Hematology, CHU, Univ. Lille, 59000, Lille, France.; INSERM UMR-S1172, 59000, Lille, France.; Nassar AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, 02115, USA.; Capelletti M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Huynh D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Bustoros M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Sklavenitis-Pistofidis R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Tahri S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Hornburg K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Dumke H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Itani MM; Massachusetts General Hospital, Boston, MA, 02114, USA.; Boehner CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Liu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; AlDubayan SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Keats JJ; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, 85004, USA.; Stewart C; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Mehr S; Multiple Myeloma Research Foundation, Norwalk, CT, 06851, USA.; Auclair D; Multiple Myeloma Research Foundation, Norwalk, CT, 06851, USA.; Schlossman RL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Steensma DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Laubach JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Harvard Medical School, Boston, MA, 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Soiffer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Trippa L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.; Getz G; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA.; Massachusetts General Hospital, Boston, MA, 02114, USA.; Neuberg DS; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.; Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA. irene_ghobrial@dfci.harvard.edu.; Harvard Medical School, Boston, MA, 02115, USA. irene_ghobrial@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA. irene_ghobrial@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Dutta AK; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Alberge JB; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Lightbody ED; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Boehner CJ; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Dunford A; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Sklavenitis-Pistofidis R; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Mouhieddine TH; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Cowan AN; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Su NK; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Horowitz EM; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Barr H; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Hevenor L; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Beckwith JB; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Perry J; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Cao A; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Lin Z; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Kuhr FK; Menarini Silicon Biosystems, Huntingdon Valley, Pennsylvania.; Mastro RGD; Menarini Silicon Biosystems, Huntingdon Valley, Pennsylvania.; Nadeem O; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Greipp PT; Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota.; Stewart C; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Auclair D; Multiple Myeloma Research Foundation, Norwalk, Connecticut.; Getz G; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Cancer Center and Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Ghobrial IM; Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE